Acadian Asset Management »

Legend Biotech 2 Adr Rep Ord shares owned by Acadian Asset Management

Quarter-by-quarter ownership of Legend Biotech 2 Adr Rep Ord (LEGN) shares owned by Acadian Asset Management from 13F filings

Historical chart of Acadian Asset Management investment in Legend Biotech 2 Adr Rep Ord

Tip: Access up to 7 years of quarterly data

All positions including Legend Biotech 2 Adr Rep Ord held by Acadian Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Legend Biotech 2 Adr Rep Ord by Acadian Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $13M 582k 21.72
2023-06-30 $17k 248 68.55

More positions owned by Acadian Asset Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Amazon (AMZN)
Bk Nova Cad (BNS)
JPMorgan Chase & Co. (JPM)
Toronto Dominion Bk Ont Com New (TD)
Deutsche Bank A G Namen Akt (DB)
Ubs Group SHS (UBS)
Broadcom Ord Shs (AVGO)
Booking Holdings (BKNG)
Citigroup Com New (C)
Telefonaktiebolaget Lm Erics Adr B Sek 10 (ERIC)

View all positions for Acadian Asset Management

Top funds holding Legend Biotech 2 Adr Rep Ord

FMR
Suvretta Capital Management
Westfield Capital Management Company
Hillhouse Capital Advisors
Deerfield Management Company
BlackRock
Point72 Asset Management
Artisan Partners Limited Partnership
Goldman Sachs Group
Henderson Group
Alliancebernstein
State Street Corporation
Braidwell
Davern Capital Partners
Matthews International Capital Management

View all funds holding Legend Biotech 2 Adr Rep Ord